Krebs Biochemicals & Industries Ltd.(IN:KREBSBIO)
₹59.00+0.12 (+0.20%)
IN:KREBSBIO
Krebs Biochemicals & Industries Ltd. Revenue
₹59.00
At close:+0.12 (+0.20%)
Want to see IN:KREBSBIO full AI Analyst Report?
Krebs Biochemicals & Industries Ltd. (KREBSBIO) Revenue
0 Followers
Krebs Biochemicals & Industries Ltd. Revenue
Krebs Biochemicals & Industries Ltd. had a revenue of 57.90M in the quarter ending Sep 30, 2026, with -17.09%. This bring the company's revenue in the last twelve months to 268.57M, Increased 6.43%. In the fiscal year ending Mar 31, 2026, Krebs Biochemicals & Industries Ltd. had annual revenue of 237.32M with -45.21% growth.
- Revenue (ttm)
- 268.57M
- Revenue Growth
- -1.32%
- P/S Ratio
- 5.36
- Revenue/Employee
- INR 1,671,239
- Employees
- 142
- Market Cap
- INR 1.27B
Revenue Chart
Krebs Biochemicals & Industries Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 237.32M | -195.80M | -45.21% |
| Mar 31, 2025 | 433.12M | -71.10M | -14.10% |
| Mar 31, 2024 | 504.21M | -17.13M | -3.29% |
| Mar 31, 2023 | 521.34M | -75.69M | -12.68% |
| Mar 31, 2022 | 597.03M | 70.20M | 13.32% |
| Mar 31, 2021 | 526.84M | 202.88M | 62.63% |
| Mar 31, 2020 | 323.95M | -47.38M | -12.76% |
| Mar 31, 2019 | 371.33M | 117.23M | 46.14% |
| Mar 31, 2018 | 254.09M | 237.14M | 1398.80% |
| Mar 31, 2017 | 16.95M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:KREBSBIO | 268.57M |
| IN:ALPA | 1.16B |
| IN:BALPHARMA | 3.34B |
| IN:BIOFILCHEM | 343.13M |
| IN:PAR | 1.08B |
| IN:VIVIMEDLAB | 699.89M |

